Company: FORL
Filing Date: 2025-04-30
Form Type: 10-K
Source: 0001213900-25-037576
Chunk: 1532

Company: Four Leaf Acquisition Corp
Filing Date: 2025-04-30
Form: 10-K
Item: Item 8
Chunk 1532
---
 that closing conditions would
not be satisfied at the Closing (subject to a 30-days cure period for breaches that are curable), provided that such right to terminate
will not be available to either party if it has breached in any material respect its obligations se forth in the Merger Agreement;

(iv)by either the Company
or Xiaoyu Dida if any Order (as defined in the Merger Agreement) having the effect of prohibiting or preventing the consummation of the
Closing shall be in effect and shall have become final and non-appealable; provided, however, that the right to terminate this shall
not be available to a party if such Order was due to such party’s breach of or failure to perform any of its representations, warranties,
covenants or agreements set forth in the Merger Agreement;

(v)by either the Company or Xiaoyu Dida if the CSRC Filing Notice has
not been obtained by the Outside Date;

(vi)by either Company or Xiaoyu Dida if Company stockholder approval
shall not have been obtained by reason of the failure to obtain the required vote upon a vote held at the special meeting or any adjournment
or postponement thereof; or

(vii)by the Company if Xiaoyu Dida shareholder approval shall not have
been obtained by reason of the failure to obtain the required vote at the general meeting duly convened therefor or at any adjournment
or postponement thereof.

If the Merger
Agreement is validly terminated, none of the parties to the Merger Agreement will have any liability or further obligation under the Merger
Agreement.

F-12

Notice
from the Nasdaq Stock Market

On September 24, 2024,
the Company received a letter (the “September Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market
LLC (“Nasdaq”) informing the Company that, for the last 36 consecutive business days, the Market Value of Listed Securities
(“MVLS”) for the Company was below the $35 million minimum MVLS requirement for continued listing on the Nasdaq Capital Market
under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). The September Notice is a notification of deficiency, not a notice
of imminent delisting, and has no current effect on the listing or trading of the Company’s securities. In accordance with Nasdaq
Listing Rule 5810(c)(3)(C), the Company will